ARA-290

ARA-290 Product Description — Research Use Only

ARA-290, also known as Cibinetide, is a synthetic research peptide derived from the structure of erythropoietin, commonly known as EPO. It is designed for research involving the innate repair receptor, a pathway associated with tissue protection, inflammation response, cellular repair, and nerve-related signaling.

Research on ARA-290 has most commonly focused on nerve function, inflammation response, tissue protection, cellular repair, neuropathy-related research, and small-fiber nerve studies. Published studies describe ARA-290 as a non-erythropoietic EPO-derived peptide, meaning it was designed to study tissue-protective activity without stimulating red blood cell production like full EPO.

ARA-290 is commonly studied for:

• Nerve function — how nerve cells respond to stress, injury, and repair signals

• Inflammation response — pathways connected to reducing inflammatory signaling

• Tissue protection — how cells and tissues respond to damage or stress

• Cell repair — biological pathways involved in recovery and restoration

• Small-fiber nerve research — studies involving small sensory and autonomic nerve fibers

• Pain-signaling pathways — how nerve-related signaling changes after stress or injury

• Innate repair receptor activity — how ARA-290 interacts with repair-related receptor pathways

ARA-290 has been studied because it may activate repair and protective signaling pathways without the red-blood-cell-stimulating effects associated with erythropoietin. Research has explored its role in small-fiber neuropathy, metabolic nerve-related complications, inflammatory signaling, and nerve-fiber repair markers.

For research use only. Not for human consumption, medical use, diagnostic use, or therapeutic application.